Evidence map›Paper›PMID 24432301›Full record

ArticleAnnals of translational medicine2013

Effect of high fat-diet and obesity on gastrointestinal motility.

Mazen Al Mushref, Shanthi Srinivasan

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Annals of translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03841578 (Effects of Dark Chocolate on Gastrointestinal Motility in Healthy Subjects), which is not on this map. Cited by 68 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 5 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03841578 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effects of Dark Chocolate on Gastrointestinal Motility in Healthy Subjects

TypeinterventionalSponsorUniversity of BariRan2019 to 2020Enrolled10ConditionsGastrointestinal MotilityArmsHealthy
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 5 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. High Prevalence and Low Incidence of Constipation Among Glucagon-Like Peptide-1 Receptor Agonist Users.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mazen Al MushrefDivision of Digestive Diseases, Emory University, 615 Michael Street, Atlanta, GA 30322, and Atlanta VA Medical Center, Decatur, GA, USA.
Shanthi SrinivasanDivision of Digestive Diseases, Emory University, 615 Michael Street, Atlanta, GA 30322, and Atlanta VA Medical Center, Decatur, GA, USA.
Atlanta VA Medical Center · US

Funding

Mechanism of Enteric NeuropathyR01DK080684 · NIDDK · EMORY UNIVERSITY · PI Shanthi K Srinivasan · 2009 to 2026
$6.1M
NIDDK NIH HHS R01 DK080684
6 · The paper itself

Abstract

Obesity is highly prevalent worldwide and is associated with significant morbidity and mortality. The focus of this review is to delineate the changes in gastrointestinal motility observed in obesity. A systematic review of the published literature on obesity and gastrointestinal motility was performed. Here, we describe the current understanding of the changes in obesity in the esophagus, stomach, small intestine and colon. Major findings include supportive evidence for increased gastroesophageal reflux disease and esophageal motility disorders in obesity, and a rapid gastric emptying time seen in obese individuals. The proximal small intestinal transit seems to be increased in obesity and this may be secondary to efficient nutrient absorption and subsequent lack of nutrient-induced satiety signals conveyed from the small intestine. In obesity, there is some evidence for delayed colonic transit as well as a reduction in colonic serotonin availability. The molecular mechanisms underlying altered motility in obesity could be secondary to reduced cannabinoids or its receptor cannabinoid receptor 1 (CB1) expression as well as due to loss of neuronal nitric oxide synthase (nNOS) neurons. The interactions of diet and obesity and the alteration of microbiota in this setting are just being explored and may offer novel insights into the changes of gastrointestinal motility in obesity.

Indexed as

constipationdiarrheaenteric neuronsgastric emptyinggastrointestinal motilityObesity

Identifiers

PMID24432301
PMCPMC3890396
OpenAlexW2162954467

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.